These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 12497543)
41. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis. Snydman DR Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417 [No Abstract] [Full Text] [Related]
42. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Isada CM; Yen-Lieberman B; Lurain NS; Schilz R; Kohn D; Longworth DL; Taege AJ; Mossad SB; Maurer J; Flechner SM; Mawhorter SD; Braun W; Gordon SM; Schmitt SK; Goldman M; Long J; Haug M; Avery RK Transpl Infect Dis; 2002 Dec; 4(4):189-94. PubMed ID: 12535261 [TBL] [Abstract][Full Text] [Related]
43. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Fisher RA Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345 [TBL] [Abstract][Full Text] [Related]
44. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients. Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203 [TBL] [Abstract][Full Text] [Related]
45. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176 [TBL] [Abstract][Full Text] [Related]
46. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Kaplan CS; Petersen EA; Icenogle TB; Copeland JG; Villar HV; Sampliner R; Minnich L; Ray CG Arch Intern Med; 1989 Sep; 149(9):2095-100. PubMed ID: 2549896 [TBL] [Abstract][Full Text] [Related]
47. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder. Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008 [TBL] [Abstract][Full Text] [Related]
48. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Strippoli GF; Hodson EM; Jones C; Craig JC Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954 [TBL] [Abstract][Full Text] [Related]
49. Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations. Gracia-Ahufinger I; Gutiérrez-Aroca J; Cordero E; Vidal E; Cantisán S; del Castillo D; Martín-Gandul C; Rivero A; Torre-Cisneros J Transplantation; 2013 Apr; 95(8):1015-20. PubMed ID: 23407543 [TBL] [Abstract][Full Text] [Related]
50. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Razonable RR; Emery VC; Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905 [TBL] [Abstract][Full Text] [Related]
51. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies. Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840 [TBL] [Abstract][Full Text] [Related]
52. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736 [TBL] [Abstract][Full Text] [Related]
53. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. Humar A; Kumar D; Gilbert C; Boivin G J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447 [TBL] [Abstract][Full Text] [Related]
54. Panresistant cytomegalovirus in a kidney transplant recipient. Yost SE; Echeverria A; Jie T; Kaplan B Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702 [TBL] [Abstract][Full Text] [Related]
55. Prevention of cytomegalovirus following solid organ transplantation: a literature review. Kowalsky S; Arnon R; Posada R Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075 [TBL] [Abstract][Full Text] [Related]
56. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients. Gagermeier JP; Rusinak JD; Lurain NS; Alex CG; Dilling DF; Wigfield CH; Love RB Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023 [TBL] [Abstract][Full Text] [Related]
57. Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature. Rolling KE; Jorgenson MR; Descourouez JL; Mandelbrot DA; Redfield RR; Smith JA Pharmacotherapy; 2017 Oct; 37(10):1258-1271. PubMed ID: 28699311 [TBL] [Abstract][Full Text] [Related]